We describe two cases of terbinafine-associated hepatic injury, in whi
ch a mixed cholestatic-hepatocellular type of hepa titis was present.
In both cases extrahepatic cholestasis and viral hepatitis were exclud
ed and involvement of other drugs was unlikely. In the first patient a
ll abnormalities have disappeared, but in the second patient alkaline
phosphatase, aminotransferase and gamma-glutamyl transferase levels ha
ve remained elevated (follow up 3 months after cessation of treatment
with terbinafine). Most likely, the terbinafine-associated hepatic inj
ury in these patients was caused by an idiosyncratic rather than a dir
ect hepatotoxic reaction. (C) Journal of Hepatology.